A common anti-fungal treatment called itraconazole may be useful in treating basal cell carcinoma — the most common form of skin cancer, according to a study that was published in the Journal of Clinical Oncology. The study tested itraconazole’s effectiveness in treating patients with multiple basal cell carcinoma tumors. Researchers at the Stanford University School of Medicine carried out a phase-2 clinical trial with 29 patients who had a total of 101 tumors. Within a month, the size and spread of tumors had decreased in most patients, they found. Read more here.
Study mentioned: Kim DJ, et al. Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma. J Clin Oncol. 2014 Feb 3. [Epub ahead of print] PMID: 24493717
No comments:
Post a Comment